Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism

Article Abstract:

Women who have an abortion early in the pregnancy may still have fetal blood cells in their blood, a condition called fetal cell microchimerism. The presence of fetal blood cells in a woman's blood has been linked to the development of autoimmune diseases.

Author: Bianchi, Diana W., Farina, Antonio, Weber, William, Delli-Bovi, Laurent C., DeRiso, Matthew, Williams, John M., Klinger, Katherine W.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2001
Health aspects, Maternal-fetal exchange, Autoimmune diseases, Mosaicism

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


High levels of fetal cell-free DNA in maternal serum: A risk factor for spontaneous preterm delivery

Article Abstract:

The relationship between the concentration of fetal cell-free DNA in maternal serum and the duration of pregnancy in women with high risk for preterm delivery due to preterm labor or preterm premature rupture of the membranes is examined. Findings reveal that an increased risk of spontaneous preterm delivery was related to high concentrations of fetal cell-free DNA in maternal serum.

Author: Romero, Roberto, Gomez, Ricardo, Bianchi, Diana W., Farina, Antonio, Chaiworapongsa, Tinnakorn, LeShane, Erik S., Rizzo, Nicola
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2005
United States, Science & research, Premature labor, Fetal tissues, Premature labour

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Fetal cell identifiers: results of microscope slide-based immunocytochemical studies as a function of gestational age and abnormality

Article Abstract:

Fetal cells may change their antigens as the fetus grows. Antigens are proteins on the surface of every cell. Researchers studied the expression of certain antigens on fetal cells taken from fetal blood. The expression of some of the antigens analyzed declined as the fetus grew older. This means that tests for those antigens would not be able to detect the cells. And that in turn means doctors would not be able to detect fetal cells in the mother's blood. Testing fetal cells in the mother's blood for genetic abnormalities is a non-invasive method for detecting these genetic disorders.

Author: Berry, Stanley M., Wapner, Ronald J., Bianchi, Diana W., Farina, Antonio, Williams, John M., Zheng, Yun-Ling, Zhen, Dong Kai
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1999
Diagnosis, Fetal blood, Genetic disorders, Diagnosis, Noninvasive, Noninvasive diagnosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research
Similar abstracts:
  • Abstracts: The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults
  • Abstracts: Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. A randomized trial of multivitamin supplements and HIV disease progression and mortality
  • Abstracts: Presence of ribonucleic acid in human spermatozoa: differences in content between normal and abnormal spermatozoa
  • Abstracts: HHS criticizes research centers for inaction on patient safety. FDA tightens human oversight
  • Abstracts: Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Focal modification of electrical conduction in the heart by viral gene transfer
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.